Agkura Personal Score
Breast Cancer Detection (Aid for dense breast tissue)
CommercialActive
Key Facts
Indication
Breast Cancer Detection (Aid for dense breast tissue)
Phase
Commercial
Status
Active
Company
About OncoTAb
OncoTAb is a private, pre-revenue biotech company leveraging its patented tMUC1-targeting antibody platform to address unmet needs in oncology. Its initial focus is the commercial launch of the Agkura Personal Score, a blood-based diagnostic test for breast cancer detection in women with dense breasts, which represents a significant market opportunity. Beyond diagnostics, the company has a preclinical pipeline exploring the same targeting agent for therapeutic applications, including radioimmunotherapy and CAR-T cell therapies for breast and pancreatic cancers.
View full company profile